A Phase 3b, Double-Blind, Randomized Study to Determine the Efficacy and Safety of Pioglitazone HCl and Metformin HCl Fixed-Dose Combination Therapy [metformin/pioglitazone] Compared to Pioglitazone HCl [pioglitazone] Monotherapy and to Metformin HCl [metformin] Monotherapy in the Treatment of Subjects With Type 2 Diabetes.
Phase of Trial: Phase III
Latest Information Update: 09 Jun 2013
At a glance
- Drugs Metformin/pioglitazone (Primary) ; Metformin; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 18 Oct 2009 Results presented at the 20th World Diabetes Congress (WDC).
- 01 Oct 2009 Results presented at the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History